News
12-12-2013, 03:42 AM
Omission of radiotherapy is a reasonable option for women age 65 or older who receive hormone therapy after breast-conserving surgery for hormone receptor-positive, axillary node-negative breast cancer, according to results of the PRIME 2 trial presented at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
More... (http://www.medicalnewstoday.com/releases/270016.php)
More... (http://www.medicalnewstoday.com/releases/270016.php)